Research News
Cleveland Clinic shares insights from KEYNOTE-522 regimen adoption for TNBC treatment
Reporting real-world effects of the KEYNOTE-522 regimen outside of the breast cancer clinical trial helps clinicians and patients know what to expect from use of this treatment.
Network-based analyses uncover how neuroinflammation-causing microglia in Alzheimer’s disease form
The study strengthens the connection between changes in microglia and Alzheimer’s disease and identifies drugs that may stop or reverse these changes.
Predictive modeling addresses healthcare disparities, identifies at-risk patients who may need stomach cancer screening
The model uses a patient’s records to estimate their gastric cancer risk and flag individuals who need preventative stomach cancer screening.